Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Clinical/translational cancer immunotherapy

Original research

Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition

Online download statistics by month:

Online download statistics by month: November 2022 to August 2024

	Abstract	Full	Pdf
Nov 2022	1165	1179	396
Dec 2022	301	303	74
Jan 2023	279	281	72
Feb 2023	186	187	69
Mar 2023	148	149	44
Apr 2023	122	123	47
May 2023	95	97	34
Jun 2023	90	91	36
Jul 2023	124	124	37
Aug 2023	132	132	34
Sep 2023	89	90	32
Oct 2023	90	90	51
Nov 2023	109	111	44
Dec 2023	68	69	33
Jan 2024	82	82	44
Feb 2024	84	85	44
Mar 2024	98	102	67
Apr 2024	114	115	52
May 2024	91	92	43
Jun 2024	80	83	35
Jul 2024	125	127	51
Aug 2024	71	73	36
Total	3743	3785	1375